Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | TAS1R3 | Q7RTX0 | 4/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 4/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15015675 | 0.91 | MME (0.46) | MMESMN1; SMN2TAS1R3TAS1R1FOLH1 | |
| SCHEMBL9911582 | 0.90 | SMN1; SMN2 (0.44) | MMESMN1; SMN2TAS1R3TAS1R1CA14 | |
| SCHEMBL12868880 | 0.90 | SMN1; SMN2 (0.44) | MMESMN1; SMN2TAS1R3TAS1R1CA14 | |
| SCHEMBL5514853 | 0.90 | SMN1; SMN2 (0.44) | MMESMN1; SMN2TAS1R3TAS1R1CA14 | |
| SCHEMBL6947237 | 0.86 | MME (0.39) | MMESMN1; SMN2TAS1R3TAS1R1CA14 | |
| SCHEMBL14316099 | 0.84 | BIRC2 (0.41) | MMESMN1; SMN2TAS1R3TAS1R1BIRC2 | |
| SCHEMBL6800777 | 0.84 | MME (0.45) | MMESMN1; SMN2TAS1R3TAS1R1FOLH1 | |
| SCHEMBL6945661 | 0.84 | ADAM17 (0.41) | MMESMN1; SMN2TAS1R3TAS1R1CA14 | |
| SCHEMBL20444140 | 0.83 | SMN1; SMN2 (0.39) | MMESMN1; SMN2TAS1R3TAS1R1CA14 | |
| SCHEMBL8166025 | 0.80 | MMP2 (0.40) | MMETAS1R3TAS1R1FOLH1RNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117843450-A | Novel magnesium ethoxide carrier and preparation method of Ziegler-Natta catalyst | 宜昌苏鹏科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-115894751-B | 1-butene polymerization catalyst and preparation method and application thereof | 北京石油化工工程有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117843450-A | Novel magnesium ethoxide carrier and preparation method of Ziegler-Natta catalyst | 宜昌苏鹏科技有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-115894751-B | 1-butene polymerization catalyst and preparation method and application thereof | 北京石油化工工程有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-114341254-B | Health care articles comprising random propylene-ethylene copolymers | SABIC环球技术有限责任公司 | 2024-01-09 | — | — | CN | disclosed |
| EP-3353146-B1 | SYNTHESIS OF SUBSTITUTED AMIDOBENZOATE COMPOUNDS, THE COMPOUNDS OBTAINED AND THE USE THEREOF AS PHTHALATE FREE INTERNAL ELECTRON DONOR FOR POLYMERIZATION OF OLEFINS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-10-25 | — | — | EP | disclosed |
| CN-116622010-A | Composite carrier type olefin polymerization catalyst and preparation method and application thereof | 广东石油化工学院 | 2023-08-22 | — | — | CN | disclosed |
| CN-107922694-B | Process for producing low emission polypropylene | SABIC环球技术有限责任公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-108349873-B | Synthesis of substituted amidobenzoate compounds and their use as phthalate-free internal electron donors | SABIC环球技术有限责任公司 | 2022-12-23 | — | — | CN | disclosed |
| US-20220315746-A1 | HEALTHCARE ARTICLE COMPRISING A RANDOM PROPYLENE-ETHYLENE COPOLYMER | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-10-06 | — | — | US | disclosed |
| EP-4025642-A1 | HEALTHCARE ARTICLE COMPRISING A RANDOM PROPYLENE-ETHYLENE COPOLYMER | SABIC Global Technologies B.V. (NL) | 2022-07-13 | — | — | EP | disclosed |
| US-20160176998-A1 | CATALYST SYSTEM FOR POLYMERISATION OF AN OLEFIN | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2016-06-23 | — | — | US | disclosed |
| EP-3033348-A1 | CATALYST SYSTEM FOR POLYMERISATION OF AN OLEFIN | Saudi Basic Industries Corporation (SA) | 2016-06-22 | — | — | EP | disclosed |
| CN-105636967-A | Catalyst system for olefin polymerization | SAUDI BASIC IND CORP | 2016-06-01 | — | — | CN | disclosed |
| WO-2015091981-A2 | CATALYST SYSTEM FOR POLYMERISATION OF AN OLEFIN | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015091984-A1 | PROCATALYST FOR POLYMERIZATION OF OLEFINS | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015091980-A1 | CATALYST SYSTEM FOR POLYMERIZATION OF AN OLEFIN | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015091966-A1 | CATALYST SYSTEM FOR POLYMERIZATION OF AN OLEFIN | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015091982-A1 | CATALYST SYSTEM FOR POLYMERISATION OF AN OLEFIN | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015022298-A1 | CATALYST SYSTEM FOR POLYMERISATION OF AN OLEFIN | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2015-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160176998-A1 | CATALYST SYSTEM FOR POLYMERISATION OF AN OLEFIN | AOC2, SOD1, ODC1 | MME 4719/4885SMN1; SMN2 1488/4885TAS1R3 4763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.